Barrington Research Lowers Henry Schein (NASDAQ:HSIC) Price Target to $99.00

Henry Schein (NASDAQ:HSICGet Rating) had its price objective cut by Barrington Research from $102.00 to $99.00 in a report published on Wednesday, MarketBeat Ratings reports. They currently have an outperform rating on the stock. Barrington Research also issued estimates for Henry Schein’s Q3 2022 earnings at $1.10 EPS, Q4 2022 earnings at $1.27 EPS, FY2022 earnings at $4.82 EPS, Q1 2023 earnings at $1.35 EPS, Q2 2023 earnings at $1.15 EPS, Q3 2023 earnings at $1.29 EPS, Q4 2023 earnings at $1.39 EPS, FY2023 earnings at $5.17 EPS and FY2024 earnings at $5.69 EPS.

A number of other equities research analysts also recently weighed in on the stock. The Goldman Sachs Group downgraded shares of Henry Schein from a buy rating to a neutral rating and dropped their price target for the stock from $93.00 to $85.00 in a research note on Thursday, July 21st. Robert W. Baird downgraded shares of Henry Schein from an outperform rating to a neutral rating and lowered their target price for the company from $103.00 to $88.00 in a research note on Tuesday, June 14th. Piper Sandler lowered their target price on shares of Henry Schein from $100.00 to $96.00 in a research note on Tuesday. William Blair reissued a market perform rating on shares of Henry Schein in a research report on Tuesday, May 3rd. Finally, Stifel Nicolaus lowered their price objective on shares of Henry Schein from $90.00 to $80.00 in a research report on Friday, June 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of Hold and an average target price of $87.14.

Henry Schein Trading Up 1.7 %

HSIC opened at $75.38 on Wednesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.83 and a quick ratio of 0.91. The company has a market cap of $10.26 billion, a price-to-earnings ratio of 16.18, a price-to-earnings-growth ratio of 2.00 and a beta of 0.75. The firm has a 50 day simple moving average of $77.98 and a 200 day simple moving average of $81.97. Henry Schein has a fifty-two week low of $70.25 and a fifty-two week high of $92.68.

Henry Schein (NASDAQ:HSICGet Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $1.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.16. The business had revenue of $3.03 billion during the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. Henry Schein’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.11 earnings per share. On average, sell-side analysts anticipate that Henry Schein will post 4.85 earnings per share for the current year.

Insider Activity

In related news, EVP Gerald A. Benjamin sold 11,489 shares of the firm’s stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $85.47, for a total transaction of $981,964.83. Following the transaction, the executive vice president now directly owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.00% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently bought and sold shares of HSIC. Pendal Group Ltd increased its holdings in Henry Schein by 132.6% in the 1st quarter. Pendal Group Ltd now owns 3,111,253 shares of the company’s stock valued at $271,271,000 after buying an additional 1,773,481 shares during the period. American Century Companies Inc. increased its holdings in Henry Schein by 23.6% in the 1st quarter. American Century Companies Inc. now owns 3,616,273 shares of the company’s stock valued at $315,303,000 after buying an additional 691,299 shares during the period. Alberta Investment Management Corp increased its holdings in Henry Schein by 1,349.8% in the 4th quarter. Alberta Investment Management Corp now owns 580,982 shares of the company’s stock valued at $45,044,000 after buying an additional 540,908 shares during the period. Pzena Investment Management LLC bought a new position in Henry Schein in the 1st quarter valued at about $44,369,000. Finally, BlackRock Inc. increased its holdings in Henry Schein by 3.5% in the 1st quarter. BlackRock Inc. now owns 12,609,559 shares of the company’s stock valued at $1,099,427,000 after buying an additional 427,442 shares during the period. 94.30% of the stock is owned by institutional investors.

About Henry Schein

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.